Unity Biotechnology, Inc. UBX
Set alert
0.20 0.00 0.00%
At close · Jul 2
0.2001 Day range 0.2001
0.947 52-week range 2.02
- YTD
- -79.51%
- 1 year
- -84.95%
- Open
- 0.2001
- Prev close
- 0.2001
- Mkt cap
- 16.85M
- Vol
- 0
- Avg vol
- 67.22K
- EPS
- -1.28
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.2001
- High
- 0.2001
- Forward P/E
- -0.57
- Beta
- 0.83
- Short ratio
- 3.52
- Inst. own
- 20.55%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 1.24
- 200-d avg
- 1.43
- 1y target
- 7.00
Financial health
Altman Z-Score
-26.38 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.6×
FY 2016 5y median -0.7× FY 2024
P/S 0.0×
FY 2016 5y median 0.0× FY 2024
P/B 2.5×
FY 2016 5y median 1.4× FY 2024
P/FCF -0.8×
FY 2016 5y median -0.8× FY 2024
EV/EBITDA -1.3×
FY 2016 5y median -1.6× FY 2024
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2024
FCF Yield -127.0%
FY 2016 5y median -127.0% FY 2024
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2024
ROE -400.2%
FY 2016 5y median -113.2% FY 2024
ROIC -96.7%
FY 2016 5y median -62.4% FY 2024
ROA -69.0%
FY 2016 5y median -60.0% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2024
Operating Income 30.2%
FY 2016 FY 2024
EPS (diluted) 43.0%
FY 2016 FY 2024
Free Cash Flow 43.8%
FY 2016 FY 2024
Financial Health
Current Ratio 2.6×
FY 2016 5y median 5.4× FY 2024
Quick Ratio 2.6×
FY 2016 5y median 5.4× FY 2024
Debt / Equity 3.6×
FY 2016 5y median 0.9× FY 2024
Net Debt / EBITDA -0.6×
FY 2016 5y median -0.5× FY 2024
Interest Coverage 0.0×
FY 2016 5y median -16.2× FY 2024
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31